Medicinal Chemistry Journal of Medicinal Chemistry
Autophagy-tethering degrader clears HBV core protein
- TK-96 joins a capsid assembly modulator (NVR3-778) to an LC3-binding ligand (ispinesib), a first-in-class autophagy-tethering degrader of HBV core protein.
- It routes both wild-type and drug-resistant core protein to autophagosomes for lysosomal clearance, rather than only blocking capsid assembly.
- Antiviral activity in HBV-replicating and infected hepatocyte models far exceeded the parent modulator, and oral dosing in carrier mice lowered viral replication, liver core protein and serum antigens.
Beating the parent modulator by a wide margin is the payoff you expect from an ATTEC, but I'd want a non-LC3-binding ispinesib analog as control, plus ATG5/ATG7 knockout, to show the effect is truly autophagy-dependent. Ispinesib is also a kinesin Eg5 inhibitor, so off-target mitotic toxicity worries me. Next step: shorten the linker and try a cleaner LC3 binder.
Paper: Journal of Medicinal Chemistry ↗ ATTEC-Based Autophagic Elimination of HBV Core Protein Achieves Potent Viral Suppression